Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update

TJ Smith, K Bohlke, GH Lyman, KR Carson… - Journal of Clinical …, 2015 - ascopubs.org
Purpose To update the 2006 American Society of Clinical Oncology guideline on the use of
hematopoietic colony-stimulating factors (CSFs). Methods The American Society of Clinical …

Scales to assess the quality of randomized controlled trials: a systematic review

SA Olivo, LG Macedo, IC Gadotti, J Fuentes… - Physical …, 2008 - academic.oup.com
Background and Purpose The methodological quality of randomized controlled trials (RCTs)
is commonly evaluated in order to assess the risk of biased estimates of treatment effects …

Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

M Tomblyn, T Chiller, H Einsele, R Gress… - Bone marrow …, 2009 - nature.com
Guidelines for preventing infectious complications among hematopoietic cell transplant
recipients: a global perspective | Bone Marrow Transplantation Skip to main content Thank you …

There was evidence of convergent and construct validity of Physiotherapy Evidence Database quality scale for physiotherapy trials

LG Macedo, MR Elkins, CG Maher, AM Moseley… - Journal of clinical …, 2010 - Elsevier
OBJECTIVE: To evaluate the convergent and construct validity of the Physiotherapy
Evidence Database (PEDro) scale used to rate the methodological quality of randomized …

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable …

V Gupta, MS Tallman, W He, BR Logan… - Blood, The Journal …, 2010 - ashpublications.org
We compared the outcomes of unrelated donor (URD, n= 358) with human leukocyte
antigen (HLA)–matched sibling donor (MSD, n= 226) transplantations in patients with acute …

Escalas y listas de evaluación de la calidad de estudios científicos

FC da Silva, BAV Arancibia… - Revista Cubana de …, 2013 - medigraphic.com
El objetivo de este estudio fue identificar las escalas de evaluación de la calidad
metodológica de artículos científicos y de las listas de verificación de la calidad de …

Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis

WJFM van der Velden, AHE Herbers… - British journal of …, 2014 - Wiley Online Library
Infection remains one of the most prominent complications after cytotoxic treatment for
cancer. The connection between neutropenia and both infections and fever has long been …

Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection

L Sung, PC Nathan, SMH Alibhai… - Annals of internal …, 2007 - acpjournals.org
Background: Benefits of prophylactic hematopoietic colony-stimulating factors (CSFs) in
adults and children receiving cancer chemotherapy or undergoing stem-cell transplantation …

Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF–licensed myeloid cells

S Tugues, A Amorim, S Spath… - Science translational …, 2018 - science.org
Allogeneic hematopoietic cell transplantation (allo-HCT) not only is an effective treatment for
several hematologic malignancies but can also result in potentially life-threatening graft …

Epidemiology of febrile neutropenia

GH Lyman, NM Kuderer - Supportive cancer therapy, 2003 - Elsevier
Febrile neutropenia (FN) continues to represent a major cause of morbidity, mortality, and
cost in patients receiving cancer chemotherapy. The reported rates of FN vary considerably …